TY - JOUR
T1 - Laparoscopic-assisted splenectomy in dogs
T2 - 18 cases (2012–2014)
AU - Wright, Tanya
AU - Singh, Ameet
AU - Mayhew, Philipp
AU - Runge, Jeffrey J.
AU - Brisson, Brigitte A.
AU - Oblak, Michelle L.
AU - Case, J. Brad
PY - 2016/4/15
Y1 - 2016/4/15
N2 - OBJECTIVE To describe the operative technique and perioperative outcome for laparoscopic- assisted splenectomy (LAS) in dogs. DESIGN Retrospective case series. ANIMALS 18 client-owned dogs. PROCEDURES Medical records of dogs with naturally occurring disease of the spleen treated by means of LAS between 2012 and 2014 were reviewed. History, signalment, results of physical examination, results of preoperative diagnostic testing, details of surgical technique, intraoperative findings including results of abdominal exploration and staging, concurrent surgical procedures, complications, histopathologic diagnoses, duration of postoperative hospitalization, and perioperative outcome were recorded. The perioperative period was defined as the time from hospital admission for LAS until discharge or death (within the same visit). RESULTS All dogs underwent initial abdominal exploration and staging via multiple 5-mm laparoscopic ports (n = 2) or a single commercially available multichannelport (16), followed by minilaparotomy with insertion of a wound retraction device, progressive exteriorization of the spleen, sealing of hilar vessels, and splenectomy. Splenectomy was performed for treatment of a splenic mass (n = 15), suspected neoplasia (2), or refractory immune-mediated disease (1). Median size (width × length) of splenic masses was 5 × 5 cm (range, 1.6 to 11.0 cm × 1.5 to 14.5 cm). Complications were limited to minor intraoperative hemorrhage in 1 dog; no patient required conversion to open laparotomy. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that LAS was technically feasible in dogs and not associated with major complications. Further evaluation is required; however, in appropriately selected patients, LAS may offer the benefits of a minimally invasive technique, including a smaller incision and improved illumination and magnification during exploration and staging.
AB - OBJECTIVE To describe the operative technique and perioperative outcome for laparoscopic- assisted splenectomy (LAS) in dogs. DESIGN Retrospective case series. ANIMALS 18 client-owned dogs. PROCEDURES Medical records of dogs with naturally occurring disease of the spleen treated by means of LAS between 2012 and 2014 were reviewed. History, signalment, results of physical examination, results of preoperative diagnostic testing, details of surgical technique, intraoperative findings including results of abdominal exploration and staging, concurrent surgical procedures, complications, histopathologic diagnoses, duration of postoperative hospitalization, and perioperative outcome were recorded. The perioperative period was defined as the time from hospital admission for LAS until discharge or death (within the same visit). RESULTS All dogs underwent initial abdominal exploration and staging via multiple 5-mm laparoscopic ports (n = 2) or a single commercially available multichannelport (16), followed by minilaparotomy with insertion of a wound retraction device, progressive exteriorization of the spleen, sealing of hilar vessels, and splenectomy. Splenectomy was performed for treatment of a splenic mass (n = 15), suspected neoplasia (2), or refractory immune-mediated disease (1). Median size (width × length) of splenic masses was 5 × 5 cm (range, 1.6 to 11.0 cm × 1.5 to 14.5 cm). Complications were limited to minor intraoperative hemorrhage in 1 dog; no patient required conversion to open laparotomy. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that LAS was technically feasible in dogs and not associated with major complications. Further evaluation is required; however, in appropriately selected patients, LAS may offer the benefits of a minimally invasive technique, including a smaller incision and improved illumination and magnification during exploration and staging.
UR - http://www.scopus.com/inward/record.url?scp=84962407659&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962407659&partnerID=8YFLogxK
M3 - Article
C2 - 27031418
AN - SCOPUS:84962407659
VL - 248
SP - 916
EP - 922
JO - Journal of the American Veterinary Medical Association
JF - Journal of the American Veterinary Medical Association
SN - 0003-1488
IS - 8
ER -